Document Detail

Combining antiplatelet and anticoagulant therapies.
MedLine Citation:
PMID:  19573725     Owner:  NLM     Status:  MEDLINE    
Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies for ischemic events resulting from coronary atherosclerotic disease. Dual antiplatelet therapy (aspirin plus a thienopyridine, usually clopidogrel) has assumed a central role in the treatment of acute coronary syndromes and after coronary stent deployment. In addition to antiplatelet therapy, anticoagulant therapy might be indicated for stroke prevention in a variety of conditions that include atrial fibrillation, profound left ventricular dysfunction, and after mechanical prosthetic heart valve replacement. For this reason, the use of triple antithrombotic therapy (a dual antiplatelet regimen plus warfarin) is expected to become more prominent, given an aging patient population. But although triple therapy can prevent both thromboembolism and stent thrombosis, it is also associated with significant bleeding hazards. Furthermore, when bleeding events do occur, the challenge of balancing the risk of stent thrombosis or stroke and the need for hemostasis requires considerable expertise. It is both prudent and timely to review treatment strategies that employ combinations of antiplatelet and anticoagulant therapies as well as strategies aimed at reducing bleeding risk in patients treated with these therapies.
David R Holmes; Dean J Kereiakes; Neal S Kleiman; David J Moliterno; Giuseppe Patti; Cindy L Grines
Related Documents :
7776995 - Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation an...
7952425 - Lack of degradation of antithrombin iii by tissue-type plasminogen activator or plasmin.
8996255 - Medical issues and emergencies in the dermatology office.
1557005 - Rationale for antithrombotic therapy in atrial fibrillation.
10878195 - Arrhythmogenic right ventricular dysplasia. an illustrated review highlighting developm...
19357245 - Hemodialysis-induced cardiac injury: determinants and associated outcomes.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  54     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-03     Completed Date:  2009-07-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  95-109     Citation Subset:  AIM; IM    
Mayo Clinic Department of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / therapeutic use*
Coronary Artery Disease / blood,  drug therapy*
Drug Therapy, Combination
Evidence-Based Medicine / methods
Platelet Aggregation Inhibitors / therapeutic use*
Treatment Outcome
Reg. No./Substance:
0/Anticoagulants; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intravascular ultrasound registration/integration with coronary angiography.
Next Document:  Serial intravascular ultrasound analysis of the main and side branches in bifurcation lesions treate...